Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
21-valent pneumokokkenconjugaatvaccin veilig en immunogeen bij gezonde volwassenen
mei 2023 | Pneumonie, Vaccinatie